(Q30363930)

20 June 2017

Glycosidase inhibitors: a patent review (2008-2013). (English)

1 reference

20 June 2017

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24958352%20AND%20SRC:MED&resulttype=core&format=json

Nuno M. F. S. A. Cerqueira

9 June 2020

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24958352%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Maria J. Ramos

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24958352%20AND%20SRC:MED&resulttype=core&format=json

Pedro Alexandrino Fernandes

9 June 2020

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24958352%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

1

Natércia F Brás

1 reference

20 June 2017

Nuno Mfsa Cerqueira

2

1 reference

20 June 2017

language of work or name

English

0 references

publication date

24 June 2014

1 reference

Expert Opinion on Therapeutic Patents

20 June 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24958352%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24958352%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24958352%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

page(s)

857-874

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24958352%20AND%20SRC:MED&resulttype=core&format=json

The Carbohydrate-Active EnZymes database (CAZy): an expert resource for Glycogenomics

9 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.916280

Carbohydrate-binding modules from family 11: Understanding the binding mode of polysaccharides

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.916280

Molecular determinants of ligand specificity in family 11 carbohydrate binding modules: an NMR, X-ray crystallography and computational chemistry approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.916280

Structural and sequence-based classification of glycoside hydrolases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.916280

Mechanistic insights into glycosidase chemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.916280

Approaches to labeling and identification of active site residues in glycosidases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.916280

QM/MM Studies on the β-Galactosidase Catalytic Mechanism: Hydrolysis and Transglycosylation Reactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.916280

Mechanistic studies on the formation of glycosidase-substrate and glycosidase-inhibitor covalent intermediates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.916280

Molecular mechanism of the glycosylation step catalyzed by Golgi alpha-mannosidase II: a QM/MM metadynamics investigation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.916280

Structural basis for catalysis and inhibition of N-glycan processing class I alpha 1,2-mannosidases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.916280

21 January 2018

Glycosidase mechanisms

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.916280

Substituted glycals as probes of glycosidase mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.916280

Conformational analyses of the reaction coordinate of glycosidases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.916280

Divergence of Catalytic Mechanism within a Glycosidase Family Provides Insight into Evolution of Carbohydrate Metabolism by Human Gut Flora

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.916280

α-Glucosidase inhibitors as potential broad based anti-viral agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.916280

Aminosugar derivatives as potential anti-human immunodeficiency virus agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.916280

Sugar-mimicking glycosidase inhibitors: bioactivity and application

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.916280

Imino sugar inhibitors for treating the lysosomal glycosphingolipidoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.916280

Ribonucleotide reductase: a critical enzyme for cancer chemotherapy and antiviral agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.916280

Glycosidase inhibitors: update and perspectives on practical use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.916280

Synthesis and partial biological evaluation of a small library of differentially-linked beta-C-disaccharides

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.916280

Iminosugars past, present and future: medicines for tomorrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.916280

Iminosugars as therapeutic agents: recent advances and promising trends

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.916280

Recent developments in design and synthesis of bicyclic azasugars, carbasugars and related molecules as glycosidase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.916280

Glycomimetics at the mirror: medicinal chemistry of L-iminosugars.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.916280

A plasmid of Rhizobium meliloti 41 encodes catabolism of two compounds from root exudate of Calystegium sepium

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.916280

Iminosugar-producing Thai medicinal plants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.916280

Pharmacological chaperone therapy for Gaucher disease: a patent review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.916280

Biological properties of D- and L-1-deoxyazasugars

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.916280

Glycosidase inhibition: assessing mimicry of the transition state

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.916280

Chemical chaperones increase the cellular activity of N370S beta -glucosidase: a therapeutic strategy for Gaucher disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.916280

Molecular interaction of imino sugars with human alpha-galactosidase: Insight into the mechanism of complex formation and pharmacological chaperone action in Fabry disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.916280

Castanospermine, A 1,6,7,8-tetrahydroxyoctahydroindolizine alkaloid, from seeds of Castanospermum australe

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.916280

Swainsonine: an inhibitor of glycoprotein processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.916280

Overview of ribonucleotide reductase inhibitors: an appealing target in anti-tumour therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.916280

Synthesis and glycosidase inhibition of the enantiomer of (-)-steviamine, the first example of a new class of indolizidine alkaloid

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.916280

Cellular effects of deoxynojirimycin analogues: uptake, retention and inhibition of glycosphingolipid biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.916280

Thiosugars: new perspectives regarding availability and potential biochemical and medicinal applications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.916280

Absolute stereostructure of potent alpha-glucosidase inhibitor, Salacinol, with unique thiosugar sulfonium sulfate inner salt structure from Salacia reticulata

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.916280

Kotalanol, a potent alpha-glucosidase inhibitor with thiosugar sulfonium sulfate structure, from antidiabetic ayurvedic medicine Salacia reticulata.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.916280

Thiolactomycin and related analogues as novel anti-mycobacterial agents targeting KasA and KasB condensing enzymes in Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.916280

Hijacking a biosynthetic pathway yields a glycosyltransferase inhibitor within cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.916280

Loco intoxication: indolizidine alkaloids of spotted locoweed (Astragalus lentiginosus).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.916280

Docking and SAR studies of salacinol derivatives as alpha-glucosidase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.916280

Design and synthesis of 5a-carbaglycopyranosylamime glycosidase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.916280

Recent developments of transition-state analogue glycosidase inhibitors of non-natural product origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.916280

The biosynthesis of acarbose and validamycin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.916280

Nucleotidylation of unsaturated carbasugar in validamycin biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.916280

Oseltamivir (Tamiflu) and its potential for use in the event of an influenza pandemic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.916280

Pandemic influenza: an inconvenient mutation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.916280

Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.916280

Alpha-glucosidase inhibitors with a 4,5,6,7-tetrachlorophthalimide skeleton pendanted with a cycloalkyl or dicarba-closo-dodecaborane group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.916280

Inhibitory activity of corn-derived bisamide compounds against alpha-glucosidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.916280

Schulzeines A-C, new alpha-glucosidase inhibitors from the marine sponge Penares schulzei

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.916280

Structure-activity relationships for alpha-glucosidase inhibition of baicalein, 5,6,7-trihydroxyflavone: the effect of A-ring substitution

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.916280

QM/MM Study of the Catalytic Mechanism of GalNAc Removal from GM2 Ganglioside Catalyzed by Human β-HexosaminidaseA

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.916280

DFT studies on the β-glycosidase catalytic mechanism: The deglycosylation step

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.916280

Docking and molecular dynamics studies on the stereoselectivity in the enzymatic synthesis of carbohydrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.916280

Kojibiose (2-O-α-D-Glucopyranosyl-D-Glucose): Isolation and Structure: Isolation from Hydrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2014.916280

The Trehalase Inhibitor Salbostatin, a Novel Metabolite fromStreptomyces albus, ATCC21838

21 January 2018

1 reference

9 March 2024

https://opencitations.net/index/api/v1/citations/10.1002/ANIE.199418441

New alpha-amylase inhibitor, trestatins. I. Isolation, characterization and biological activities of trestatins A, B and C

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.36.1157

Identifiers

DOI

10.1517/13543776.2014.916280

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24958352%20AND%20SRC:MED&resulttype=core&format=json

release_qyurm5pf7fggvclwvkxhaujzvy

9 June 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/qyurm5pf7fggvclwvkxhaujzvy

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference